Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Marc Kahn who wrote (101)	12/29/1997 10:29:00 PM
From: geewiz	Respond to of 534

Hi Marc, Wow! You've really made a great contribution! I know I will benfit from this work, thanks very much! Hope I can follow up with some useful information or articles. Thanks tons! Happy new years all! art

To: Marc Kahn who wrote (101)	1/4/1998 12:23:00 PM
From: Ron Coby	Respond to of 534

I recently attended a meeting in portland with the management of elan and the mgt. of bjct on their joint deal and was I impressed.They addressed all the competing technologies and the potental market and timing of their monotoring product and I'll tell you this stock at 1.25 has alot of potentail here.The way elans mgt talked about bjct and Jim oshea you would've thought bjct was a big sophisticated co. with awesome managment team going big places with elan.Elan is also opening up alot of other opportunities for bjct.It was hard to believe that bjct was a penny stock after I left this meeting.I'm also showing bjct to the analyst who cover those other competing co's you mentioned and bjct is the only one with continuous monotoring so you can imagine their response when i showed bjct/elan info.Ron